KRTX News
Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires (update)
HC Wainwright & Co. Maintains Neutral on Karuna Therapeutics, Maintains $330 Price Target
Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires
Catalyst Watch: Oracle earnings, Arm IPO lockup, and triple-witching day
Validea Detailed Fundamental Analysis - KRTX
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates GMGI, KRTX, SIX, AVRO
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates GMGI, KRTX, SIX, AVRO
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CVLY, PGTI, KRTX
KRTX Events
No data
KRTX Monitor News
No data
KRTX Earnings Analysis